Optimal management of cytomegalovirus retinitis in patients with AIDS.
Cytomegalovirus (CMV) retinitis is the most common cause of vision loss in patients with acquired immunodeficiency syndrome (AIDS). CMV retinitis afflicted 25% to 42% of AIDS patients in the pre-highly active antiretroviral therapy (HAART) era, with most vision loss due to macula-involving retinitis or retinal detachment. The introduction of HAART significantly decreased the incidence and severity of CMV retinitis. Optimal treatment of CMV retinitis requires a thorough evaluation of the patient's immune status and an accurate classification of the retinal lesions. When retinitis is diagnosed, HAART therapy should be started or improved, and anti-CMV therapy with oral valganciclovir, intravenous ganciclovir, foscarnet, or cidofovir should be administered. Selected patients, especially those with zone 1 retinitis, may receive intravitreal drug injections or surgical implantation of a sustained-release ganciclovir reservoir. Effective anti-CMV therapy coupled with HAART significantly decreases the incidence of vision loss and improves patient survival. Immune recovery uveitis and retinal detachments are important causes of moderate to severe loss of vision. Compared with the early years of the AIDS epidemic, the treatment emphasis in the post- HAART era has changed from short-term control of retinitis to long-term preservation of vision. Developing countries face shortages of health care professionals and inadequate supplies of anti-CMV and anti-HIV medications. Intravitreal ganciclovir injections may be the most cost effective strategy to treat CMV retinitis in these areas.
Stewart
Michael W
MW
Department of Ophthalmology, Mayo School of Medicine, Jacksonville, FL, USA. stewart.michael@mayo.edu
Drugs. 1998 Jul;56(1):115-46
9664203
J Clin Virol. 2002 Feb;24(1-2):67-77
11744430
Herpes. 2004 Dec;11(3):77-86
15960905
N Engl J Med. 1997 Jul 10;337(2):83-90
9211677
Ophthalmology. 2000 May;107(5):877-81; discussion 881-3
10811078
Retina. 2006 Feb;26(2):165-9
16467672
Am J Ophthalmol. 2007 Feb;143(2):334-5
17258523
J Clin Pharmacol. 1999 Aug;39(8):800-4
10434231
Clin Exp Ophthalmol. 2005 Jun;33(3):317-29
15932540
Am J Ophthalmol. 2007 Nov;144(5):781-5
17707328
J Infect Dis. 2005 Aug 15;192(4):640-9
16028133
Am J Ophthalmol. 2005 Nov;140(5):900-2
16310469
Am J Ophthalmol. 1982 Apr;93(4):393-402
6280503
Int Ophthalmol Clin. 2004 Summer;44(3):33-9
15211175
J Infect Dis. 1995 Oct;172(4):951-6
7561215
N Engl J Med. 1981 Dec 10;305(24):1431-8
6975437
Ethiop Med J. 2007 Oct;45(4):327-34
18326342
Br J Ophthalmol. 2009 Jan;93(1):88-90
18952644
Br J Ophthalmol. 1999 May;83(5):540-5
10216051
J Infect Dis. 2001 Dec 15;184(12):1598-602
11740736
Am J Ophthalmol. 1997 Aug;124(2):141-57
9262538
Clin Infect Dis. 2007 Apr 1;44(7):1001-8
17342657
Ocul Immunol Inflamm. 1999 Dec;7(3-4):173-7
10611725
Clin Infect Dis. 1996 Apr;22 Suppl 1:S43-7; discussion S47-9
8785256
Am J Public Health. 1993 Oct;83(10):1385-9
8214225
Drug Saf. 1999 Sep;21(3):203-24
10487398
Antiviral Res. 2006 Sep;71(2-3):154-63
16765457
J Infect Dis. 1993 Dec;168(6):1506-9
8245536
HIV Clin Trials. 2005 May-Jun;6(3):136-46
16192248
Lancet Infect Dis. 2006 Aug;6(8):461-2
16870523
Ophthalmology. 2004 Dec;111(12):2232-9
15582079
Ann Intern Med. 1988 Dec 15;109(12):963-9
2848436
Am J Ophthalmol. 2003 Jan;135(1):26-34
12504693
J Clin Virol. 2004 Jun;30(2):115-33
15125867
Am J Ophthalmol. 1993 May 15;115(5):575-82
8098183
Am J Ophthalmol. 2008 Jan;145(1):12-22
18154751
MMWR Recomm Rep. 2004 Dec 17;53(RR-15):1-112
15841069
Clin Infect Dis. 2006 Nov 1;43(9):1143-51
17029132
N Engl J Med. 1981 Dec 10;305(24):1425-31
6272109
N Engl J Med. 2002 Apr 11;346(15):1119-26
11948271
J Indian Med Assoc. 2008 May;106(5):292-4
18839634
Drugs. 1999 Aug;58(2):325-45
10473024
Niger Postgrad Med J. 2008 Mar;15(1):24-7
18408779
J Microbiol Immunol Infect. 2000 Mar;33(1):45-8
10806964
Am J Ophthalmol. 2005 Jun;139(6):1028-34
15953432
J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):972-7
15220705
Clin Infect Dis. 2003 Nov 15;37(10):1365-73
14583871
Retina. 1999;19(4):274-80
10458290
Pharmacoeconomics. 2007;25(5):413-28
17488139
Am J Ophthalmol. 2002 Jan;133(1):48-61
11755839
Ophthalmology. 2004 Dec;111(12):2224-31
15582078
Ophthalmology. 1996 Jul;103(7):1078-83
8684797
Ophthalmology. 2006 Apr;113(4):684-94
16581429
J Infect Dis. 1998 Mar;177(3):770-3
9498461
Curr Opin Ophthalmol. 2007 Nov;18(6):487-92
18163001
J Med Assoc Thai. 2005 Jan;88(1):103-7
15960227
Trans Am Ophthalmol Soc. 1995;93:623-83
8719695
J Infect Dis. 2003 Mar 1;187(5):777-84
12599051
N Engl J Med. 1996 Aug 8;335(6):377-83
8676931
Br J Ophthalmol. 1994 Feb;78(2):120-4
8123619
J Infect. 2007 Nov;55(5):464-9
17714788
Am J Ophthalmol. 1992 Dec 15;114(6):742-7
1334376
Am J Ophthalmol. 2001 Apr;131(4):457-67
11292409
Herpes. 2007 Dec;14(3):66-71
18371289
Arch Ophthalmol. 1996 Jan;114(1):23-33
8540847
J Acquir Immune Defic Syndr (1988). 1992;5(11):1069-74
1357151
Curr HIV/AIDS Rep. 2008 Aug;5(3):120-5
18627660
Br J Ophthalmol. 1999 Mar;83(3):339-42
10365044
Antimicrob Agents Chemother. 1998 Sep;42(9):2240-4
9736542
N Engl J Med. 1995 Sep 7;333(10):615-20
7637721
Retina. 2004 Jun;24(3):376-82
15187659
Drugs. 1990 Apr;39(4):597-638
2161731
Arch Ophthalmol. 1989 Dec;107(12):1759-66
2556989
Ophthalmology. 2007 Feb;114(2):334-9
17270681
AIDS Res Ther. 2007 May 08;4:9
17488505
Lancet. 2006 Mar 11;367(9513):817-24
16530575
Retina. 2001;21(1):1-9
11217922
Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):264-71
18780260
N Engl J Med. 1994 Mar 24;330(12):868-9
8114855
Pharmacoeconomics. 2001;19(12):1199-208
11772155
N Engl J Med. 1999 Apr 8;340(14):1063-70
10194235
Am J Ophthalmol. 2000 Jan;129(1):9-15
10653406
Am J Ophthalmol. 1987 Jan 15;103(1):17-23
3026186
Am J Ophthalmol. 2008 Mar;145(3):397-408
18282490
J Infect Dis. 1981 Feb;143(2):188-92
6260871
Ophthalmology. 2007 Apr;114(4):787-93
17210182
Clin Infect Dis. 2004 Apr 15;38(8):1159-66
15095223
Clin Pharmacokinet. 1999 Aug;37(2):167-76
10496303
Am J Med Sci. 1999 May;317(5):318-35
10334120
AIDS. 2005 Apr 29;19(7):735-8
15821403
Ophthalmology. 2007 Apr;114(4):780-6
17258320
J Infect Dis. 1999 Mar;179(3):697-700
9952380
Drugs. 1994 Sep;48(3):455-84
7527763
Ophthalmology. 1991 Sep;98(9):1348-53; discussion 1353-5
1658703
Arch Ophthalmol. 2008 Aug;126(8):1143-6
18695113
N Engl J Med. 1997 Jul 10;337(2):105-14
9211681
Ophthalmology. 2006 Aug;113(8):1432-40
16766032
Niger J Clin Pract. 2007 Dec;10(4):283-6
18293635
Ophthalmology. 2005 May;112(5):771-9
15878056
Med J Aust. 1992 Sep 21;157(6):370-3
1333036
Drugs. 2005;65(6):859-78
15819597
HIV Clin Trials. 2006 Jan-Feb;7(1):1-9
16632459
J Infect Dis. 1992 Dec;166(6):1223-7
1358986